Expanded Proliferation Centers (PC) Identify a Histological Subtype of Chronic Lymphocytic Leukemia ("Accelerated" CLL) with Adverse Clinical Outcome

被引：0
|
作者：
Gine, E.
Villamor, N.
Lopez-Guillermo, A.
Camos, M.
Martinez, D.
Esteve, J.
Calvo, X.
Abrisqueta, P.
Rozman, C.
Montserrat, E.
Campo, E.
Bosch, F.
Martinez, A.
机构：
[1] Hosp St Joan Deu, Barcelona, Spain
[2] UB, Hosp Clin, IDIBAPS, Barcelona, Spain
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1330
引用
收藏
页码：297A / 297A
页数：1
相关论文
共 50 条
  • [41] B-Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia (CLL) from and Monoclonal B-Cell Lymphocytosis (MBL) Based on Clinical Outcome
    Shanafelt, Tait
    Kay, Neil E.
    Jenkins, Gregory
    Call, Timothy G.
    Zent, Clive S.
    Jelinek, Diane F.
    Boysen, Justin
    Schwager, Susan
    Bowen, Deborah
    Zakko, Liam
    Slager, Susan L.
    Hanson, Curtis A.
    BLOOD, 2008, 112 (11) : 718 - 718
  • [42] Proliferation Centers in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Show Enhanced Expression of the Therapeutic Target PI3K and Other Targets of B-cell Receptor (BCR) Signaling
    Jain, Sarika
    Bullock, Grant C.
    Swerdlow, Steven H.
    Gibson, Sarah E.
    MODERN PATHOLOGY, 2016, 29 : 355A - 355A
  • [43] THE HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA IN A SINGLE CENTRE OF HEMATOLOGY: CLINICAL AND BIOLOGICAL CHARACTERISTICS AND OUTCOME IN 315 PATIENTS AFFECTED BY CLL DIAGNOSED DURING THE LAST 11 YEARS
    Laurenti, L.
    Autore, F.
    Tarnani, M.
    Vannata, B.
    Innocenti, I.
    Santini, F.
    Marietti, S.
    Za, T.
    Bellesi, S.
    Sica, S.
    Leone, G.
    HAEMATOLOGICA, 2012, 97 : 527 - 527
  • [44] CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia
    D'Arena, G
    Musto, P
    Cascavilla, N
    Dell'Olio, M
    Di Renzo, N
    Perla, G
    Savino, L
    Carotenuto, M
    LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) : 109 - 114
  • [45] Outcome of immunotherapeutic rescue strategies for clinical relapse of high-risk chronic lymphocytic leukemia (CLL) in patients after allogeneic hematopoietic stem cell transplantation (HSCT)
    Hahn, M.
    Dietrich, S.
    Herth, I.
    Hegenbart, U.
    Walter, E.
    Rieger, M.
    Stadtherr, P.
    Bondong, A.
    Ho, A. D.
    Dreger, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 51 - 51
  • [46] Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: Validation of a simplified method suitable for multi-center clinical studies
    Hayes, Gregory M.
    Busch, Robert
    Voogt, Jason
    Siah, Iche M.
    Gee, Tracy A.
    Hellerstein, Marc K.
    Chiorazzi, Nicholas
    Rai, Kanti R.
    Murphy, Elizabeth J.
    LEUKEMIA RESEARCH, 2010, 34 (06) : 809 - 815
  • [47] PROGRESSIVE TELOMERE SHORTENING IS PART OF THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND IMPACTS CLINICAL OUTCOME: EVIDENCES FROM A STUDY ON PATIENTS WITH A LONG TERM FOLLOW-UP
    Genuardi, E.
    Ghione, P.
    Rossi, D.
    Drandi, D.
    Mantoan, B.
    Barbero, D.
    Bernocco, E.
    Monitillo, L.
    Cerri, M.
    Ruggeri, M.
    Omede, P.
    Deambrogi, L.
    De Paoli, L.
    Passera, R.
    Coscia, M.
    Cavallo, F.
    Massaia, M.
    Boccadoro, M.
    Gaidano, G.
    Ladetto, M.
    Ferrero, S.
    HAEMATOLOGICA, 2016, 101 : S23 - S24
  • [48] Fludarabine, Ara-c, novantrone and dexamethasone plus Campath-1H for the treatment of patients with chronic lymphocytic leukemia (CLL) and adverse clinical and biologic prognostic features.
    Mauro, Francesca R.
    Giammartini, Elena
    De Propris, Maria S.
    Gentile, Giuseppe
    Nanni, Mauro
    Ghia, Emanuela M.
    Della Starza, Irene
    Del Giudice, Ilaria
    Santangelo, Simona
    Marinelli, Marilisa
    Brugnoletti, Fulvia
    Minotti, Clara
    Capria, Vera
    Guarini, Anna
    Foa, Robert
    BLOOD, 2006, 108 (11) : 801A - 801A
  • [49] Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial
    Shanafelt, Tait D.
    Wang, Victoria
    Kay, Neil E.
    Hanson, Curtis A.
    O'Brien, Susan M.
    Barrientos, Jacqueline C.
    Jelinek, Diane F.
    Braggio, Esteban
    Leis, Jose F.
    Zhang, Cong Christina
    Coutre, Steven
    Barr, Paul M.
    Cashen, Amanda F.
    Mato, Anthony R.
    Singh, Avina
    Mullane, Michael P.
    Little, Richard F.
    Erba, Harry P.
    Stone, Richard M.
    Litzow, Mark
    Tallman, Martin S.
    BLOOD, 2019, 134
  • [50] B-CELL COUNT AND TIME TO FIRST TREAMENT: DIFFERENTIATING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FROM MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) BASED ON CLINICAL OUTCOME: THE GIMEMA EXPERIENCE
    Molica, S.
    Mauro, F.
    Callea, V.
    Giannarelli, D.
    Lauria, F.
    Cortelezzi, A.
    Liso, V.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 328 - 328
12345